This interpretation is backed up by the fact that UCP2 polymorphisms have not been reported in genome-wide association studies (GWAS) that investigated genetic factors underlying risk of Alzheimer’s disease (e.g. [37]) or Parkinson’s disease (e.g. [38]). The gene discussed is UCP2; the disease is early-onset autosomal dominant Alzheimer disease.